Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
SAR422459 · 1 trial · 1 indication
The number and percentage of patients with treatment emergent adverse events
| Arm | Type | Description |
|---|---|---|
| Long Term Follow up | OTHER | Long term follow up in all patients who received SAR422459 in previous study TDU13583 |
| Name | Type | Description |
|---|---|---|
| Long term follow up in all patients who received SAR422459 in previous study TDU13583 | DRUG | Blood draw for the laboratory assessment |
Inclusion Criteria: Patients must meet ALL of the following criteria: 1. Provide signed and dated written informed consent and any locally required authorization (e.g., Health Insurance Portability and Accountability Act \[HIPAA\]) 2. Must have been enrolled in protocol TDU13583 (SG1/001/10) 3. Mu...